0001209191-15-036093.txt : 20150424
0001209191-15-036093.hdr.sgml : 20150424
20150424162049
ACCESSION NUMBER: 0001209191-15-036093
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150423
FILED AS OF DATE: 20150424
DATE AS OF CHANGE: 20150424
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daly James M
CENTRAL INDEX KEY: 0001560782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 15792097
MAIL ADDRESS:
STREET 1: INCYTE CORPORATION EXPERIMENTAL STATION
STREET 2: RTE 141 & HENRY CLAY RD. BLDG E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-04-23
0
0000879169
INCYTE CORP
INCY
0001560782
Daly James M
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP, Chief Commercial Officer
Common Stock
2015-04-23
4
M
0
1203
16.62
A
4724
D
Common Stock
2015-04-23
4
M
0
15464
16.62
A
20188
D
Common Stock
2015-04-23
4
M
0
5556
18.32
A
25744
D
Common Stock
2015-04-23
4
S
0
22223
107.67
D
3521
D
Common Stock
2015-04-23
4
M
0
14718
64.55
A
18239
D
Common Stock
2015-04-23
4
S
0
14718
107.67
D
3521
D
Non-Qualified Stock Option (right to buy)
16.62
2015-04-23
4
M
0
1203
0.00
D
2019-10-21
Common Stock
1203
3610
D
Non-Qualified Stock Option (right to buy)
16.62
2015-04-23
4
M
0
15464
0.00
D
2019-10-21
Common Stock
15464
46391
D
Non-Qualified Stock Option (right to buy)
18.32
2015-04-23
4
M
0
5556
0.00
D
2020-02-08
Common Stock
5556
22321
D
Non-Qualified Stock Option (right to buy)
64.55
2015-04-23
4
M
0
14718
0.00
D
2021-01-20
Common Stock
14718
19624
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
Represents weighted average sale price. Actual sale prices ranged from $106.88 - $108.22.
Beginning October 22, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
/s/ Eric Siegel, Attorney-In-Fact
2015-04-24